Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib in relapsed or refractory follicular lymphoma
NCT03126019Phase 2Completed
- Sponsor
- Incyte
- Start
- Mar 2018
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 2 trial of parsaclisib in follicular lymphoma (FL), sponsored by Incyte. Started Mar 2018; status: completed.
02
Drugs
parsaclisib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT03126019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03126019.